Clinical Trials on Locoregionally Advanced in United Kingdom
Total 2701 results
-
University of California, Los AngelesUniversity of California, San Francisco; University of California, IrvineActive, not recruitingAdvanced Cancer | Advance Care Planning | Advance DirectivesUnited States
-
Aegera TherapeuticsTerminated
-
University College, LondonRecruiting
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
Eli Lilly and CompanyCompletedAdvanced CancerUnited Kingdom
-
Cancer Research UKCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
BeiGeneCompletedAdvanced Solid TumorsUnited Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCancer, Advanced Solid TumorsUnited Kingdom
-
PfizerCompletedAdvanced Non-Hematologic MalignanciesUnited Kingdom
-
Stemline Therapeutics, Inc.CompletedStudy of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors With Advanced Solid TumorsAdvanced Solid TumorUnited Kingdom
-
Cancer Research UKTerminatedAdvanced Solid TumoursUnited Kingdom
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited Kingdom, United States
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompleted
-
Heidelberg Pharma AGTerminatedAdvanced Solid TumoursUnited Kingdom
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompletedAdvanced CancerUnited Kingdom
-
Nerviano Medical SciencesTerminatedAdvanced/Metastatic Solid TumorsUnited Kingdom, France
-
PharmaMarCompletedSpecific Advanced Solid TumorsSpain, United Kingdom
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomUnknownAdvanced Solid MalignanciesUnited Kingdom
-
King's College LondonCalouste Gulbenkian Foundation; Centro Hospitalar Lisboa CentralCompletedAdvanced CancerUnited Kingdom
-
Eisai Inc.Completed
-
King's College LondonPrincess Alice HospiceCompleted
-
Liverpool University Hospitals NHS Foundation TrustUniversity of LiverpoolCompleted
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States
-
University College, LondonActive, not recruitingGynecologic Cancer | Advanced Cancer | Clear Cell TumorUnited Kingdom
-
Heidelberg Pharma AGTerminatedAdvanced Solid TumoursUnited Kingdom
-
T3 Pharmaceuticals AGRecruiting
-
zr Pharma & GmbHCompletedAdvanced Solid TumorsUnited Kingdom
-
AstraZenecaSyneos HealthCompletedAdvanced Solid TumoursUnited States, Spain, Korea, Republic of, United Kingdom
-
Taiho Oncology, Inc.TerminatedAdvanced Solid TumorsItaly, Spain, United States, Netherlands, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, United Kingdom
-
OSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited Kingdom
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, Canada, United Kingdom
-
BioNTech SEGenmabRecruitingAdvanced Malignant Solid TumorUnited States, United Kingdom
-
AstraZenecaCompletedSafety and Tolerability, | Advanced Solid Malignancy, | Pharmacokinetics, Pharmacodynamics, | Tumour Response,United Kingdom, Netherlands
-
Exscientia AI LimitedGT Apeiron LLCRecruitingAdvanced Solid TumorUnited Kingdom, Belgium
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
AstraZenecaCompletedAdvanced Solid Metastatic TumorUnited Kingdom
-
Genelux CorporationCompletedAdvanced Cancers (Solid Tumors)United Kingdom
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
Oxford University Hospitals NHS TrustUniversity of Oxford; Cancer Research UK; National Institute for Health Research...Completed
-
Nottingham University Hospitals NHS TrustActive, not recruitingAdvanced Chronic Liver DiseaseUnited Kingdom
-
Vall d'Hebron Institute of OncologyTaisho Pharmaceutical Co., Ltd.; Roche Pharma AG; Iqvia Pty Ltd; Janssen, LPRecruitingAdvanced Solid TumorSpain, France, Germany, Netherlands, Sweden, United Kingdom, Italy
-
UCB Biopharma SRLCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Nuvectis Pharma, Inc.RecruitingAdvanced Solid TumorUnited States, United Kingdom
-
Cancer Research UKTeon Therapeutics, Inc.Recruiting